Data / Drug companies / Potassium chloride extended-release
Potassium chloride extended-release: 13 companies and 22 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Potassium chloride extended-release is listed in the FDA National Drug Code Directory by 13 companies, with 22 products in commercial distribution. 22 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, extended release; tablet, and the newest product started marketing on July 2, 2025.
The request: Get every company that lists potassium chloride extended-release in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 13
- Products
- 22
- Generic (ANDA) products
- 22 (100.0%)
- Application numbers
- 2
- Routes
- Oral
- Brand names
- Potassium Chloride
- openFDA record search
- api.fda.gov
Companies that list potassium chloride extended-release
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Solco Healthcare US, LLC | 3 | tablet | Generic drugs (ANDA) | April 30, 2019 |
| A-S Medication Solutions | 2 | tablet, extended release | Generic drugs (ANDA) | January 30, 2021 |
| BluePoint Laboratories | 2 | tablet | Generic drugs (ANDA) | January 30, 2021 |
| Bryant Ranch Prepack | 2 | tablet, extended release | Generic drugs (ANDA) | January 30, 2021 |
| Granules India Limited | 2 | tablet | Generic drugs (ANDA) | January 30, 2021 |
| Granules Pharmaceuticals Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | January 30, 2021 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 2 | tablet, extended release | Generic drugs (ANDA) | January 30, 2021 |
| Remedyrepack Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | July 2, 2025 |
| Atlantic Biologicals Corp. | 1 | tablet, extended release | Generic drugs (ANDA) | January 30, 2021 |
| Preferred Pharmaceuticals Inc. | 1 | tablet, extended release | Generic drugs (ANDA) | May 23, 2022 |
| Proficient Rx LP | 1 | tablet, extended release | Generic drugs (ANDA) | January 30, 2021 |
| Proficient Rx LP | 1 | tablet, extended release | Generic drugs (ANDA) | January 30, 2021 |
| Redpharm Drug | 1 | tablet, extended release | Generic drugs (ANDA) | January 30, 2021 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, extended release | 15 | 68.2% |
| Tablet | 7 | 31.8% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 22 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Osmotic Laxative | 22 |
| Potassium Salt | 22 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.